Could a simple blood test predict clot risk in PCOS?

NCT ID NCT06339567

First seen Aug 18, 2026 · Last updated Aug 18, 2026

Summary

This study looks at whether different types of polycystic ovary syndrome (PCOS) have different blood clotting profiles. Researchers will measure several biological markers in blood samples from women with PCOS and compare them based on the presence of insulin resistance. The goal is to understand if certain PCOS phenotypes are more prone to venous thrombosis, which could help personalize treatment and monitoring.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Blood tests measuring several thrombotic biological markers (C protein, S protein, CRP us, Factor VIII, TFPI, nAPCsr, SHBG, nTMsr)
What this could lead to
If successful, this could help doctors tailor monitoring and contraceptive choices for women with PCOS based on their specific phenotype, potentially reducing the risk of blood clots.
What could go wrong
This is an observational study, so it cannot prove cause and effect. The findings may not apply to all populations, and the markers measured are only intermediate indicators, not actual clot events.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Paris Saint Joseph

    Paris, France, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.